| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date |
|---|
| Hairy cell leukemia and COVID-19 adaptation of treatment guidelines | [1]Michael Grever, [2]Leslie Andritsos, [3]Versha Banerji, [4]Jacqueline C. Barrientos, [5]Seema Bhat, [6]James S Blachly, [7]Timothy Call, [8]Matthew Cross, [9]Claire Dearden, [10]Judit Demeter, ..., [21]Francesco Lauria, [22]Gerard Lozanski, [23]Sameer A Parikh, [24]Jae Park, [25]Aaron Polliack, ... [Full author list] | Leukemia [curation] | DOI: 10.1038/S41375-021-01257-7
| COVID-19 [curation] | 2021-05-04 |
| Incorporating molecular biomarkers into the continuum of care in chronic lymphocytic leukemia | [1]Paul J Hampel, [2]Sameer A Parikh, [3]Timothy G. Call [Full author list] | Leukemia & Lymphoma [curation] | DOI: 10.1080/10428194.2020.1869966
PubMed: 33410372 | biomarker [curation]; chronic lymphocytic leukemia [curation] | 2021-01-07 |
| Incidence and risk of tumor lysis syndrome in patients with relapsed chronic lymphocytic leukemia (CLL) treated with venetoclax in routine clinical practice | [1]Amber B Koehler, [2]Nelson Leung, [3]Timothy G. Call, [4]Kari G Rabe, [5]Sara J Achenbach, [6]Wei Ding, [7]Saad S Kenderian, [8]Jose F Leis, [9]Yucai Wang, [10]Eli Muchtar, [11]Suzanne R Hayman, [12]Paul J Hampel, [13]Heidi D Finnes, [14]Susan M. Schwager, [15]Susan L Slager, [16]Neil E Kay, [17]Sameer A Parikh [Full author list] | Leukemia & Lymphoma [curation] | DOI: 10.1080/10428194.2020.1768384
PubMed: 32449401 | tumor lysis syndrome [curation]; chronic lymphocytic leukemia [curation] | 2020-05-25 |
| Chronic lymphocytic leukemia in 2020: a surfeit of riches? | [1]Sameer A Parikh, [2]Robert Peter Gale, [3]Neil E Kay [Full author list] | Leukemia [curation] | DOI: 10.1038/S41375-020-0852-7
PubMed: 32393844 | chronic lymphocytic leukemia [curation] | 2020-05-11 |
| Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index | [1]Geffen Kleinstern, [2]Daniel R O'Brien, [3]Xing Li, [4]Shulan Tian, [5]Brian Kabat, [6]Kari G Rabe, [7]Aaron D Norman, [8]Huihuang Yan, [9]Celine M. Vachon, [10]Nicholas J Boddicker, [11]Timothy G. Call, [12]Sameer A Parikh, [13]Laura Bruins, [14]Cecilia Bonolo de Campos, ... [Full author list] | American Journal of Hematology [curation] | DOI: 10.1002/AJH.25831
PubMed: 32279347 | chronic lymphocytic leukemia [curation] | 2020-04-12 |
| The impact of dose modification and temporary interruption of ibrutinib on outcomes of chronic lymphocytic leukemia patients in routine clinical practice | [1]Sameer A Parikh, [2]Sara J Achenbach, [3]Timothy G. Call, [4]Kari G Rabe, [5]Wei Ding, [6]Jose F Leis, [7]Saad S. Kenderian, [8]Asher A Chanan-Khan, [9]Amber B Koehler, [10]Susan M. Schwager, [11]Eli Muchtar, [12]Amie L Fonder, [13]Kristen B McCullough, [14]Adrienne N Nedved, [15]Matthew D Smith, [16]Susan L Slager, [17]Neil E Kay, [18]Heidi D Finnes, [19]Tait D Shanafelt [Full author list] | Cancer Medicine [curation] | DOI: 10.1002/CAM4.2998
PubMed: 32187452 | chronic lymphocytic leukemia [curation]; ibrutinib [curation] | 2020-03-18 |
| Daratumumab as successful initial therapy for AL amyloidosis with nerve involvement | [1]Shweta Deshpande, [2]Morie A Gertz, [3]Angela Dispenzieri, [4]Shaji K Kumar, [5]Sameer A Parikh, [6]Eli Muchtar [Full author list] | Leukemia & Lymphoma [curation] | DOI: 10.1080/10428194.2020.1737688
PubMed: 32159403 | AL amyloidosis [curation] | 2020-03-11 |
| Addition of venetoclax at time of progression in ibrutinib-treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare | [1]Paul J Hampel, [2]Timothy G. Call, [3]Wei Ding, [4]Eli Muchtar, [5]Saad S. Kenderian, [6]Yucai Wang, [7]Jose F Leis, [8]Thomas E. Witzig, [9]Amber B Koehler, [10]Amie L Fonder, [11]Susan M. Schwager, [12]Kari G Rabe, [13]Daniel L Van Dyke, [14]Esteban Braggio, [15]Susan L Slager, [16]Neil E Kay, [17]Sameer A Parikh [Full author list] | American Journal of Hematology [curation] | DOI: 10.1002/AJH.25690
PubMed: 31788844 | chronic lymphocytic leukemia [curation]; ibrutinib [curation] | 2019-12-13 |
| Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes | [1]Jithma P Abeykoon, [2]Saurabh Zanwar, [3]Stephen M Ansell, [4]Morie A Gertz, [5]Shaji K Kumar, [6]Michelle Manske, [7]Anne J. Novak, [8]Rebecca King, [9]Patricia T Greipp, [10]Ronald S Go, ..., [22]Robert A Kyle, [23]S. Vincent Rajkumar, [24]Sameer A Parikh, [25]Prashant Kapoor [Full author list] | British Journal of Haematology [curation] | DOI: 10.1111/BJH.16168
PubMed: 31468508 | ibrutinib [curation] | 2019-08-29 |
| Characterization of a cryptic IGH/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies | [1]Jess F Peterson, [2]Linda B Baughn, [3]Rhett P Ketterling, [4]Beth A Pitel, [5]Stephanie A Smoley, [6]George Vasmatzis, [7]James B Smadbeck, [8]Patricia T Greipp, [9]Abhishek A Mangaonkar, [10]Carrie A Thompson, [11]Sameer A Parikh, [12]Dong Chen, [13]David S Viswanatha [Full author list] | | DOI: 10.1182/BLOODADVANCES.2019031450
PubMed: 31015206 | mantle cell lymphoma [curation] | 2019-04-01 |
| Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL | [1]Jennifer A Woyach, [2]Amy S Ruppert, [3]Nyla A Heerema, [4]Weiqiang Zhao, [5]Allison M Booth, [6]Wei Ding, [7]Nancy L Bartlett, [8]Danielle M Brander, [9]Paul M Barr, [10]Kerry Rogers, [11]Sameer A Parikh, [12]Steven Coutre, [13]Arti Hurria, ... [Full author list] | The New England Journal of Medicine [curation] | DOI: 10.1056/NEJMOA1812836
PubMed: 30501481 | ibrutinib [curation] | 2018-12-27 |
| Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings | [1]Paul J Hampel, [2]Kari G Rabe, [3]Rebecca L King, [4]Douglas Simonetto, [5]Melissa C Larson, [6]Sara J Achenbach, [7]Timothy G. Call, [8]Wei Ding, [9]Saad S Kenderian, [10]Jose F Leis, [11]Asher A Chanan-Khan, [12]Deborah A Bowen, [13]Michael J Conte, [14]Susan M. Schwager, [15]Curtis A Hanson, [16]Susan L Slager, [17]Neil E Kay, [18]Tait D Shanafelt, [19]Sameer A Parikh [Full author list] | American Journal of Hematology [curation] | DOI: 10.1002/AJH.24915
PubMed: 28940587 | lymphocyte [curation]; chronic lymphocytic leukemia [curation] | 2017-10-19 |
| Chronic myeloid leukemia: mechanisms of resistance and treatment | [1]Elias Jabbour, [2]Sameer A Parikh, [3]Hagop Kantarjian, [4]Jorge Eduardo Cortes [Full author list] | Hematology / Oncology Clinics of North America [curation] | DOI: 10.1016/J.HOC.2011.09.004
PubMed: 22054730 | chronic myeloid leukemia [curation] | 2011-10-19 |
| Frontline chemoimmunotherapy with fludarabine, cyclophosphamide, alemtuzumab, and rituximab for high-risk chronic lymphocytic leukemia | [1]Sameer A Parikh, [2]Michael J. Keating, [3]Susan O'Brien, [4]Xuemei Wang, [5]Alessandra Ferrajoli, [6]Stefan Faderl, [7]Jan A Burger, [8]Charles Koller, [9]Zeev Estrov, [10]Xavier C Badoux, [11]Susan Lerner, [12]William G Wierda [Full author list] | Blood [curation] | DOI: 10.1182/BLOOD-2011-01-329177
PubMed: 21750315 | leukemia [curation]; rituximab [curation]; lymphocyte [curation]; chronic lymphocytic leukemia [curation] | 2011-07-12 |
| The great imitator: systemic nocardiosis mimicking Richter's transformation in relapsed chronic lymphocytic leukemia | [1]Sameer A Parikh, [2]Yogesh Bhusal, [3]Stefan H Faderl, [4]William G Wierda, [5]Susan O'Brien, [6]Hagop Kantarjian, [7]Javier A Adachi, [8]Jan A Burger [Full author list] | Journal of Clinical Oncology [curation] | DOI: 10.1200/JCO.2010.29.9792
PubMed: 20823404 | leukemia [curation]; lymphocyte [curation] | 2010-09-07 |
| Phase II study of obatoclax mesylate (GX15-070), a small-molecule BCL-2 family antagonist, for patients with myelofibrosis | [1]Sameer A Parikh, [2]Hagop Kantarjian, [3]Aaron Schimmer, [4]William Walsh, [5]Ekatherine Asatiani, [6]Khaled El-Shami, [7]Elliott F Winton, [8]Srdan Verstovsek [Full author list] | Clinical Lymphoma, Myeloma & Leukemia [curation] | DOI: 10.3816/CLML.2010.N.059
PubMed: 20709666 | myelofibrosis [curation] | 2010-08-01 |
| Experience with everolimus (RAD001), an oral mammalian target of rapamycin inhibitor, in patients with systemic mastocytosis | [1]Sameer A Parikh, [2]Hagop Kantarjian, [3]Mary Ann Richie, [4]Jorge Eduardo Cortes, [5]Srdan Verstovsek [Full author list] | Leukemia & Lymphoma [curation] | DOI: 10.3109/10428190903486220
PubMed: 20038218 | sirolimus [curation]; systemic mastocytosis [curation] | 2010-02-01 |